Lutris Pharma, a clinical stage biopharmaceutical company focused on improving anti-cancer therapies by reducing cutaneous ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Tesla stock dropped in the DeepSeek sell off, but nothing like Nvidia stock. Deutsche Bank, however, believes investors ...

This is highlighted by the fact that in our data set, all four class 1 MAP2K1-mutant tumors that experienced a response to treatment were in the context of coexisting BRAF V600E mutations treated with ...

Filled with the top stories to start your day, and emergency news alerts.

Shares of semiconductor makers were dropping early Monday as a Chinese AI model triggered questions over their lofty valuations.

This study presents fundamental insights into overcoming resistance in hormone receptor-positive breast cancer by demonstrating that sustained CDK4/6 inhibitor treatment, either alone or in ...

Uniswap, the world's leading decentralized exchange in the DeFi ecosystem, has quietly launched a groundbreaking $35M UNI ...

Aromatase inhibitors (AIs) are becoming the hormonal treatment of choice for postmenopausal women with early breast cancer. Large, well-controlled clinical studies have established the efficacy ...

A study conducted at Turku PET Center in Finland showed that changes in the functioning of opioid neurotransmitters in the brain may underlie anorexia. The results were published on 12 January ...

Regardless of stage of disease, cytotoxic chemotherapy remains an important part of the treatment paradigm for breast cancer. Anthracyclines and taxanes are the most active agents; however ...

1 “This is the first trial to show that mutations in this specific signal pathway, also beyond PIK3CA, predict aspirin response, expanding the target population to more than a third of the patients ...